Women's Health Taskforce - Summary of evidence supporting the Women's Health Action Plan 2022-2023
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Women’s Health Taskforce Summary of evidence supporting the Women’s Health Action Plan 2022-2023 March 2022
Women’s Health Action Plan 2022-2023 – Evidence Summary A note on the language used in this Action Plan: This Action Plan uses the word “we” to refer to the Government and particularly the health sector. It signifies the partnership required between the Department of Health, its agencies - in particular the Health Service Executive, and organisations across the sector to implement this Action Plan. When this plan talks about “women” it is intended in the most inclusive sense of the word. It is used as shorthand to describe all those who identify as women as well as those that do not identify as women but who share women's biological realities and experiences. In using this term, we seek to include not exclude. Using gender to inform health policy is just one way of creating more targeted, personalized health services for all people in Ireland. We will commit to keep our language under constant review so that all those for whom this plan and programme are relevant see themselves reflected in it. —— 2
Women’s Health Action Plan 2022-2023 – Evidence Summary Overview Who we are affects our health, health-related behaviours and access to health services, this includes our personal history and identity, socioeconomics, and environment.1–3 For example, young people have different health needs to older people,3–5 and people in rural areas have different challenges for accessing health services compared to people in cities.6–8 In the same way, women have different health journeys than other genders: they experience different health shocks and face different supports and challenges to their health.9–11 So while overall, women living in Ireland experience good health12, there is, nevertheless, a lot we can do to improve health outcomes, behaviours and services for women across Irish society. The Women’s Health Action Plan 2022-2023 complements the existing activity underway for men, including the National Men's Health Policy.13 By examining women’s health separately, we can see where we can improve, in a targeted and effective way. For example, there is evidence that targeted initiatives, for example on breast cancer, have led to consistently improving outcomes for women,14 including survival rates in Ireland.15 What determines our health? Lots of factors, independently and together, affect our health.1 In turn, our health affects how we live.4,16,17 Major determinants of health, including some examples,1,2,18,19 are: Personal history & identity Access to services Genetics, childhood, family, Availability, cost, waiting age, culture, gender, sexual Health times, quality and identify, health history, How we feel and how experiences of care disability that affects our activities, illnesses, life expectancy, life satisfaction Socioeconomics & Behaviour environment Smoking, alcohol and drug Financial situation, education, use, exercise, road use, hand- community, job, the economy, washing, medication the physical environment adherence, health literacy —— 3
Women’s Health Action Plan 2022-2023 – Evidence Summary These factors all contribute to our health, and in turn our health affects what we do and how we view life. The determinants of health also interact in important ways.1 Women experience events such as periods, pregnancy and menopause. Some issues that affect everyone, such as autoimmune conditions,20,21 affect women disproportionately. Supports and challenges also arise in health services and behaviours. Comparing women to men in Ireland, women visit the GP more12 but have fewer positive experiences in hospital22 and women are less likely to exercise but are also less likely to smoke.12 Women also have differing health and access to services depending on their background. For example female carers, who form the majority of carers in Ireland, are more likely to have worse health and to live with financial disadvantage than the general population;23 this group experienced disproportionate challenges to their resources, resilience and human capital during the COVID-19 pandemic.24 Key Findings: What does the evidence say about women’s health in Ireland? The Department of Health and the National Women’s Council of Ireland commissioned “Evidence Base for the Development of the Women’s Health Action Plan”, published in August 2019.11 This document accrues available evidence from surveys, academic papers, and governmental and international agency reports. It establishes what is known about women in Ireland in terms of demographics, health, and engagement with health services. Its key findings (KF) are: KF1. Ireland’s demography is changing, and this should be reflected in health planning The proportion of older women in Ireland is increasing relative to other age groups. Fertility rates are declining and labour force participation is increasing. Women from diverse ethnic backgrounds form an increasing proportion of our population. Women’s health should be considered across life-cycles and backgrounds. —— 4
Women’s Health Action Plan 2022-2023 – Evidence Summary KF2. Vulnerable groups require extra consideration In Ireland, there is a socioeconomic gradient in health, health behaviours and health service use: gender, geography, poverty, age and ethnicity are among the important intersecting determinants of health that have complex effects. KF3. Targeted initiatives should focus on some particularly important facets of health Areas that require specifically targeted initiatives for women include chronic disease, mental health, sexual health, health behaviours, domestic, sexual and gender-based violence (DSGBV), ethnic background and minority status and socioeconomic inequality. KF4. Look beyond health outcomes: experience of health services should be prioritised Women’s positive engagement with health care services should be focused on as an area for improvement, although the report does not highlight major themes directly relevant to Ireland. (This has been supplemented through subsequent further work.25) KF5. Women’s health is more than reproductive health during pregnancy Women’s health policy, as it stood at the time of the report’s publication, prioritised reproductive health, particularly reproductive health during pregnancy, compared to other facets of women’s health. What did we do, based on the evidence? Based on this evidence, the Women’s Health Taskforce26 carried out in-depth research using an open-policy approach with women, their representative groups, and important stakeholders to establish (1) additional information where there are evidence gaps, for example on how health services should be improved, and (2) how action on women’s health should be prioritised and implemented.27 Details on the open policy method and radical listening are available in the Women’s Health Taskforce Process and Methodology.25,28 —— 5
Women’s Health Action Plan 2022-2023 – Evidence Summary Evidence supporting Women’s Health Action Plan Priorities 2022, linked to key findings (KF) from the Evidence Base11 (see p2) KF Motivation and Support Pillar One: Listen We will keep listening to those 5 Ensure the needs of women are properly considered. planning, delivering, and Meaningful collaboration can help ensure that the experiencing care health response is aligned with patient preferences and deliver outcomes that are important to both the clinician and patient.29–31 Introduce an annual Women’s 2,4 Health promotion improves women’s health Health Week outcomes,14,32,33 with particular consideration needed for vulnerable groups,11 who face more barriers to promotion uptake.34,35 Pillar Two: Invest We will align investment and 3 The strategic approach to investment in women’s priorities in women’s health health improves health with knock-on effects across society36 and increases governmental efficiency.37 Pillar Three: Deliver Spotlight Programme 4 Contraception 2,5 Contraception is an essential support for sexual and reproductive health and self-determination, however access is inequitable.38 Groups such as older teens and young adults (17-25s) can experience greater barriers to access and greater risk of pregnancy complications and reduced human capital.39–44 Menopause 1,5 Menopause can be a significant health shock. Its occurrence and treatment can have large, long-term physical, mental and human capital effects for those experiencing a challenging menopause,45–51 with calls for enhanced health services, education and workplace supports to support this population group.51 —— 6
Women’s Health Action Plan 2022-2023 – Evidence Summary Gynaecology and Women’s 1 Increasing access and pathways to women’s health Health Services services like gynaecological care allows patient- directed care and efficient service use,52–56 including eHealth, which can improve effectiveness and education.57 Spotlight Programme: 4 Culture of Care 4, 5 Healthcare quality can be helped through a supportive culture,58 benefiting both those delivering and receiving care, and supporting people-centred care as a coordinated, comprehensive care that accounts for broad determinants of health.10,59–61 Accessibility of Information 2,4,5 Information inaccessibility reduces service delivery use and quality, patient safety and satisfaction.62–64 Vulnerable sub-groups are particularly at risk of barriers to information access, for example sex workers, traveller, migrant and LGBTI+ communities, including trans women.65–70 Support for women in key groups 2,4,5 Service access and quality for women from minority and other key groups, who are at higher risk for poor health outcomes, is often worse than for the general population and requires specialisation.61,65–71 Core Programme: Policy & Legislation Assisted Human Reproduction 1,2,5 Fertility rates are declining72 with large potential (including surrogacy) welfare effects.73–75 Assisted human reproduction is under-regulated76 and current access models are inequitable.77,78 Reviewing access to HPV 2,5 HPV vaccine has proven effectiveness in reducing Vaccination cervical cancer risk,79 and is currently provided through a school-based immunisation programme.80 Support for Carers 2,5 Carers have worse health and life satisfaction than non-carers,23,24 the COVID-19 pandemic has further increased their burden in a setting where home-care is under-regulated.24,81 Period Poverty 1,5 Period poverty affects a significant minority of the population.82 Clear vulnerable groups are identified71 —— 7
Women’s Health Action Plan 2022-2023 – Evidence Summary and wider provision of period products is justified on equity grounds.82 Women affected by social 2,5 Women affected by social exclusion have additional exclusion or different health needs that require consideration, above and beyond that for the general population, such as women accessing supports for addiction,83 Traveller84 or Roma85 women, and homeless women.86 Innovation Programme: New 3 evidence & initiatives Research 1 There remain significant gaps in knowledge on women’s health.87–90 Better understanding of sex and gender differences on health issues and impacts can help inform and target health interventions.91,92 Postnatal women 1,2,3 There are barriers to access for post-natal care such as specialised physiotherapy93 and mental health services94,95 that provide care for issues with enduring health effects.96,97 Midlife & older women 1,2,3 Midlife is a period of major health shocks, determining health and human capital over the following decades,45–51,98 evidence supports specialised services for this group.99 Older women experience particular health challenges to a greater degree than men.100 Adolescent and young women 1,2,3 Adolescence is a crucial developmental period for developing a good foundation for health through the rest of life101; however, adolescent girls face particular challenges in areas such as body image, bullying, identity and periods.43,102 Nursing, midwifery and allied 1 Nursing, midwifery and allied health professionals health professional led solutions play an important role in improved health outcomes and health experiences for patients.103–105 We will model and lead the Nationally and internationally, there is increased changes we want to see evidence to support equality initiatives such as —— 8
Women’s Health Action Plan 2022-2023 – Evidence Summary equality budgeting,106 gender representation107 and gender mainstreaming of policies.108,109 We will work together more 1,2,5 People-centred care coordinates across agencies to effectively across the health ensure consistent, integrated care where healthcare sector to drive progress for workforces can assess wider factors influencing women women’s health.10,59,60 —— 9
Women’s Health Action Plan 2022-2023 – Evidence Summary References 1. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. The Lancet. 2012;380(9846):1011-1029. doi:10.1016/S0140-6736(12)61228-8 2. Baker M, Stabile M. Determinants of Health in Childhood. In: Glied S, Smith PC, eds. The Oxford Handbook of Health Economics. Oxford University Press; 2011. 3. McNamara A, Normand C, Whelan B. Patterns and Determinants of Health Care Utilisation in Ireland. Irish Longitudinal Study on Aging (TILDA); 2013. Accessed November 12, 2021. https://www.lenus.ie/handle/10147/301630 4. Bleakley H. Health, Human Capital, and Development. Annu Rev Econ. 2010;2(1):283-310. doi:10.1146/annurev.economics.102308.124436 5. Sheehan A, O’Sullivan R. Ageing and Public Health – an Overview of Key Statistics in Ireland and Northern Ireland. Institute of Public Health; 2020. 6. Rosenkrantz DE, Black WW, Abreu RL, Aleshire ME, Fallin-Bennett K. Health and health care of rural sexual and gender minorities: A systematic review. Stigma and Health. 2017;2(3):229-243. doi:10.1037/sah0000055 7. Afshar N, English DR, Milne RL. Rural–urban residence and cancer survival in high-income countries: A systematic review. Cancer. 2019;125(13):2172-2184. doi:10.1002/cncr.32073 8. Morrissey K, Clarke G, Ballas D, Hynes S, O’Donoghue C. Examining access to GP services in rural Ireland using microsimulation analysis. Area. 2008;40(3):354-364. doi:10.1111/j.1475-4762.2008.00844.x 9. Hawkes S, Allotey P, Elhadj AS, Clark J, Horton R. The Lancet Commission on Gender and Global Health. Lancet. 2020;396(10250):521-522. doi:10.1016/S0140-6736(20)31547-6 10. World Health Organization. Beyond the Mortality Advantage: Investigating Women’s Health in Europe.; 2015. Accessed November 11, 2021. https://www.euro.who.int/__data/assets/pdf_file/0008/287765/Beyond-the-mortality- advantage.pdf 11. Walsh K. Women’s Health in Ireland: Evidence Base for the Development of the Women’s Health Action Plan. National Women’s Council of Ireland, Department of Health, Health Service Executive; 2019. 12. Department of Health. Healthy Ireland: Summary Report 2019.; 2019. Accessed November 11, 2021. https://assets.gov.ie/41141/e5d6fea3a59a4720b081893e11fe299e.pdf 13. TBC. (TBC) National Men’s Health Policy.; 2021. —— 10
Women’s Health Action Plan 2022-2023 – Evidence Summary 14. Agide FD, Sadeghi R, Garmaroudi G, Tigabu BM. A systematic review of health promotion interventions to increase breast cancer screening uptake: from the last 12 years. Eur J Public Health. 2018;28(6):1149-1155. doi:10.1093/eurpub/ckx231 15. Department of Health. National Cancer Strategy (2017- 2026). Department of Health; 2017. Accessed November 12, 2021. health.gov.ie/wp- content/uploads/2017/07/National-Cancer-Strategy-2017-2026.pdf 16. Hokayem C, Ziliak JP. Health, Human Capital, and Life Cycle Labor Supply. American Economic Review. 2014;104(5):127-131. doi:10.1257/aer.104.5.127 17. Pelkowski JM, Berger MC. The impact of health on employment, wages, and hours worked over the life cycle. The Quarterly Review of Economics and Finance. 2004;44(1):102-121. doi:10.1016/j.qref.2003.08.002 18. Kickbusch I, Allen L, Franz C. The commercial determinants of health. The Lancet Global Health. 2016;4(12):e895-e896. doi:10.1016/S2214-109X(16)30217-0 19. Kaplan RM. The significance of quality of life in health care. Quality of Life Research. 2003;12(1):3-16. doi:10.1023/A:1023547632545 20. Angum F, Kahn T, Kaler J, Siddiqui L, Hussain A. The Prevalence of Autoimmune Disorders in Women: A Narrative Review. Cureus. 2020;12(5):e8094. Cureus. 2020;12(5). doi:10.7759/cureus.8094 21. McCarthy M. The “gender gap” in autoimmune disease. The Lancet. 2000;356(9235):1088. doi:10.1016/S0140-6736(05)74535-9 22. O’Carroll T, Boulger J, Foley C, et al. The National Inpatient Experience Survey: Findings of the 2019 Inpatient Survey.; 2019. Accessed November 11, 2021. https://yourexperience.ie/wp-content/uploads/2019/11/National-Inpatient-Experience- Survey_Report_2019-1.pdf 23. Central Statistics Office (CSO). Irish Health Survey 2019 - Carers and Social Supports. CSO; 2020. Accessed November 11, 2021. www.cso.ie/en/releasesandpublications/ep/p- ihsc/irishhealthsurvey2019-carersandsocialsupports/carers/ 24. Lafferty A, Phillips D, Dowling-Hetherington L, et al. Colliding worlds: Family carers’ experiences of balancing work and care in Ireland during the COVID-19 pandemic. Health Soc Care Community. Published online April 23, 2021. doi:10.1111/hsc.13365 25. Department of Health. (TBC) Active Listening.; 2021. 26. Women’s Health Taskforce. Women’s Health Taskforce: Campaign Website. Accessed November 11, 2021. www.gov.ie/en/campaigns/-womens-health 27. Department of Health. (TBC) Women’s Health Action Plan 2022: Priority Setting.; 2021. 28. Department of Health. (TBC) Women’s Health Action Plan 2022: Open Policy Decision Making Process.; 2021. —— 11
Women’s Health Action Plan 2022-2023 – Evidence Summary 29. Moore JE, Titler MG, Kane Low L, Dalton VK, Sampselle CM. Transforming Patient- Centered Care: Development of the Evidence Informed Decision Making through Engagement Model. Women’s Health Issues. 2015;25(3):276-282. doi:10.1016/j.whi.2015.02.002 30. Morrow M. Women’s Health in Canada. In: Morrow M, Hankivsky O, Varcoe C, eds. University of Toronto Press; 2019:355-379. doi:10.3138/9781442685604-015 31. Moss N, Daru J, Lanz D, Thangaratinam S, Khan K. Involving pregnant women, mothers and members of the public to improve the quality of women’s health research. BJOG: An International Journal of Obstetrics & Gynaecology. 2017;124(3):362-365. doi:10.1111/1471-0528.14419 32. Fowles ER, Cheng HR, Mills S. Postpartum health promotion interventions: a systematic review. Nurs Res. 2012;61(4):269-282. doi:10.1097/NNR.0b013e3182556d29 33. Kampmeijer R, Pavlova M, Tambor M, Golinowska S, Groot W. The use of e-health and m- health tools in health promotion and primary prevention among older adults: a systematic literature review. BMC Health Serv Res. 2016;16 Suppl 5(Suppl 5):290. doi:10.1186/s12913-016-1522-3 34. Burke E, McCallion E, McCarron M. An Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing. Trinity College Dublin; 2014. 35. Brooks H, Llewellyn CD, Nadarzynski T, et al. Sexual orientation disclosure in health care: a systematic review. Br J Gen Pract. 2018;68(668):e187-e196. doi:10.3399/bjgp18x694841 36. Onarheim KH, Iversen JH, Bloom DE. Economic Benefits of Investing in Women’s Health: A Systematic Review. PLOS ONE. 2016;11(3):e0150120. doi:10.1371/journal.pone.0150120 37. Curristine T, Zsuzsanna L, Journard I. Improving Public Sector Efficiency: Challenges and Opportunities. OECD Journal on Budgeting. 2007;7(1). Accessed November 11, 2021. https://www.oecd.org/gov/budgeting/43412680.pdf 38. World Health Organization. Ensuring Human Rights in the Provision of Contraceptive Information and Services: Guidance and Recommendations.; 2014. Accessed November 11, 2021. https://apps.who.int/iris/bitstream/handle/10665/102539/9789241506748_eng.pdf?sequ ence=1 39. World Health Organization. WHO Guidelines on Preventing Early Pregnancy and Poor Reproductive Outcomes among Adolescents in Developing Countries.; 2011. 40. Kane JB, Philip Morgan S, Harris KM, Guilkey DK. The educational consequences of teen childbearing. Demography. 2013;50(6):2129-2150. doi:10.1007/s13524-013-0238-9 41. Boden JM, Fergusson DM, John Horwood L. Early motherhood and subsequent life outcomes. J Child Psychol Psychiatry. 2008;49(2):151-160. doi:10.1111/j.1469- 7610.2007.01830.x —— 12
Women’s Health Action Plan 2022-2023 – Evidence Summary 42. Chen XK, Wen SW, Fleming N, Demissie K, Rhoads GG, Walker M. Teenage pregnancy and adverse birth outcomes: a large population based retrospective cohort study. International Journal of Epidemiology. 2007;36(2):368-373. doi:10.1093/ije/dyl284 43. Nic Gabhainn S, Kelly C, Gavin A. (TBC) Girls Health Policy Priorities. Health Behaviour in School Aged Children (HSBC); 2021. 44. McConnell R, Meaney S, O’Donoghue K. Influence of Cost on Contraceptive Choices Amongst University Students. Irish Medical Journal. 2021;114(6). 45. Hoga L, Rodolpho J, Gonçalves B, Quirino B. Women’s experience of menopause: a systematic review of qualitative evidence. JBI Database System Rev Implement Rep. 2015;13(8):250-337. doi:10.11124/jbisrir-2015-1948 46. Lizcano F, Guzmán G. Estrogen Deficiency and the Origin of Obesity during Menopause. Biomed Res Int. 2014;2014:757461. doi:10.1155/2014/757461 47. Stute P, Wildt L, Neulen J. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric. 2018;21(2):111-122. doi:10.1080/13697137.2017.1421925 48. Colpani V, Baena CP, Jaspers L, et al. Lifestyle factors, cardiovascular disease and all-cause mortality in middle-aged and elderly women: a systematic review and meta-analysis. Eur J Epidemiol. 2018;33(9):831-845. doi:10.1007/s10654-018-0374-z 49. Kim JE, Chang JH, Jeong MJ, et al. A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases. Sci Rep. 2020;10(1):20631. doi:10.1038/s41598-020-77534-9 50. Nappi RE, Simoncini T. Menopause transition: a golden age to prevent cardiovascular disease. The Lancet Diabetes & Endocrinology. 2021;9(3):135-137. doi:10.1016/S2213- 8587(21)00018-8 51. Grimley A, O’Keefe C. (TBC) Menopause in Ireland. Women’s Health Taskforce; 2019. 52. Bain A. A nurse-led gynaecology emergency assessment service. Nurs Times. 2006;102(50):31-32. 53. Royal College of Obstetricians and Gynaecologists. Commissioning Women’s Health Services: Advice for Clinical Commissioning Groups and NHS England.; 2013. Accessed November 11, 2021. https://www.rcog.org.uk/globalassets/documents/guidelines/guidelines--supporting- commissioners/conmmissioning_womens_health_services_july2013.pdf 54. Royal College of Obstetricians and Gynaecologists. National Heavy Menstrual Bleeding Audit: Final Report.; 2014. Accessed November 11, 2021. https://www.rcog.org.uk/globalassets/documents/guidelines/research-- audit/national_hmb_audit_final_report_july_2014.pdf 55. NHS England, NHS Improvement. Transforming Elective Care Services: Gynaecology. Learning from the Elective Care Development Collaborative.; 2019. Accessed November 11, —— 13
Women’s Health Action Plan 2022-2023 – Evidence Summary 2021. https://www.england.nhs.uk/wp-content/uploads/2019/06/gynaecology-elective- care-handbook.pdf 56. National Women and Infants Health Programme. Annual Report 2020. HSE; 2020. Accessed November 12, 2021. https://www.hse.ie/eng/about/who/acute-hospitals- division/woman-infants/national-reports-on-womens-health/ 57. Murugesu S, Galazis N, Jones BP, et al. Evaluating the use of telemedicine in gynaecological practice: a systematic review. BMJ Open. 2020;10(12):e039457. doi:10.1136/bmjopen-2020-039457 58. Mannion R, Davies H. Understanding organisational culture for healthcare quality improvement. BMJ. 2018;363. doi:10.1136/bmj.k4907 59. World Health Organization. Gender, Women and Primary Health Care Renewal: A Discussion Paper.; 2010. Accessed November 11, 2021. https://apps.who.int/iris/bitstream/handle/10665/44430/9789241564038_eng.pdf;seque nce=1 60. Ramakrishnan A, Sambuco D, Jagsi R. Women’s participation in the medical profession: insights from experiences in Japan, Scandinavia, Russia, and Eastern Europe. J Womens Health (Larchmt). 2014;23(11):927-934. doi:10.1089/jwh.2014.4736 61. Smith S. Deep End Ireland: Health Inequalities in Women. Women’s Health Taskforce; 2020. 62. Al Shamsi H, Almutairi AG, Al Mashrafi S, Al Kalbani T. Implications of Language Barriers for Healthcare: A Systematic Review. Oman Med J. 2020;35(2):e122. doi:10.5001/omj.2020.40 63. Downe S, Finlayson K, Tunçalp Ö, Gülmezoglu AM. Provision and uptake of routine antenatal services: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2019;6(6):CD012392. doi:10.1002/14651858.CD012392.pub2 64. Sadoughi F, Nasiri S, Ahmadi H. The impact of health information exchange on healthcare quality and cost-effectiveness: A systematic literature review. Comput Methods Programs Biomed. 2018;161:209-232. doi:10.1016/j.cmpb.2018.04.023 65. Sweeney LA. The psychosocial experiences of women involved in prostitution: an exploratory study. Published online 2015. Accessed November 11, 2021. https://aran.library.nuigalway.ie/handle/10379/4970 66. Collins MB, Muntean GF. Pavee Point Traveller & Roma Centre: Women’s Health Taskforce. Women’s Health Taskforce; 2021. 67. McMahon B. Working Group to Report to Government on Improvements to the Protection Process, Including Direct Provision and Supports to Asylum Seekers: Final Report.; 2015. 68. LGBTIreland. The LGBTIreland Report: National Study of the Mental Health and Wellbeing of Lesbian, Gay, Bisexual, Transgender and Intersex People in Ireland. Glen; BelongTo; Trinity College Dublin; HSE; Connecting for Life; 2016. Accessed November 12, 2021. —— 14
Women’s Health Action Plan 2022-2023 – Evidence Summary https://www.hse.ie/eng/services/list/4/mental-health-services/connecting-for- life/publications/lgbt-ireland-key-findings-pdf.pdf 69. Safer JD, Coleman E, Feldman J, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):168-171. doi:10.1097/MED.0000000000000227 70. Ryan H. (TBC) Literacy Changes Lives. National Adult Literacy Agency; Women’s Health Taskforce; 2020. 71. Ní Chinnéide F, Martyn F. (TBC) Presentation of Irish Penal Reform Trust to Women’s Health Task Force. Women’s Health Taskforce; 2020. 72. Central Statistics Office (CSO). Census of Population 2016 - Profile 4 Households and Families: Fertility. CSO Accessed November 12, 2021. www.cso.ie/en/releasesandpublications/ep/p-cp4hf/cp4hf/fty/ 73. Vos AE. Falling fertility rates: new challenges to the European welfare state. Socio- Economic Review. 2009;7(3):485-503. doi:10.1093/ser/mwp007 74. Morgan SP. Is low fertility a twenty-first-century demographic crisis? Demography. 2003;40(4):589-603. doi:10.1353/dem.2003.0037 75. Monga M, Alexandrescu B, Katz SE, Stein M, Ganiats T. Impact of infertility on quality of life, marital adjustment, and sexual function. Urology. 2004;63(1):126-130. doi:10.1016/j.urology.2003.09.015 76. Gracias CS. Reproductive surrogacy in Ireland — an ethical and legal context. Irish Journal of Medical Science (1971 -). 2021;190(3):1063-1070. doi:10.1007/s11845-020-02402-4 77. HSE. LGBT Health: Towards Meeting the Health Care Needs of Lesbian, Gay, Bisexual and Transgender People. HSE National Social Inclusion Governance Group; 2009. Accessed November 12, 2021. https://www.hse.ie/eng/services/publications/topics/sexual/lgbt- health.pdf 78. Naasan M, Waterstone J, Johnston MM, et al. Assisted reproductive technology treatment outcomes. Irish medical journal. Published online 2012. http://hdl.handle.net/10147/234511 79. Health Information and Quality Authority (HIQA). The Role of Human Papillomavirus Vaccines in Reducing the Risk of Cervical Cancer in Ireland: A Health Technology Assessment. HIQA; 2008. Accessed November 12, 2021. https://www.hiqa.ie/sites/default/files/2017-02/HTA_HPV_Full_report.pdf 80. Corcoran B, Clarke A, Barrett T. Rapid response to HPV vaccination crisis in Ireland. The Lancet. 2018;391(10135):2103. doi:10.1016/S0140-6736(18)30854-7 81. Family Carers Ireland. Caring through COVID: Life in Lockdown. Family Carers Ireland; 2020. Accessed November 12, 2021. https://familycarers.ie/media/1394/caring-through- covid-life-in-lockdown.pdf —— 15
Women’s Health Action Plan 2022-2023 – Evidence Summary 82. Government of Ireland. Period Poverty in Ireland: Discussion Paper. Department of Children, Equality, Disability, Integration and Youth; Department of Health; 2021. Accessed November 12, 2021. https://www.gov.ie/en/publication/264f4-period-poverty- in-ireland-discussion-paper-period-poverty-sub-committee-national-strategy-for-women- and-girls-20172020-february-2021/ 83. Ivers JH, Giulini F, Paul G. Supporting Women to Access Appropriate Treatment (SWAAT) Study.; 2021. Accessed November 22, 2021. https://www.drugsandalcohol.ie/34462/1/BLDATF_TDATF_SWAAT_Research_2021.pdf 84. Pavee Point Traveller and Roma Centre & Mid West Traveller Health Unit. Traveller Health Needs Assessment: County Clare.; 2019. Accessed November 22, 2021. https://www.paveepoint.ie/wp-content/uploads/2019/07/Clare-Needs-Assessment.pdf 85. Curran S. Challenges, Barriers and Misconceptions: Roma Maternal Health in Ireland. Pavee Point; 2013. Accessed November 22, 2021. https://www.paveepoint.ie/wp- content/uploads/2013/11/Roma-Maternal-Health-in-Ireland.pdf 86. Morton S, MacDonald S, Christophers L. Responding to Women with Complex Needs Who Use Substances: A Briefing Paper. University College Dublin; 2020. Accessed November 22, 2021. https://mqi.ie/content/uploads/2020/11/Responding-to-women-with-complex- needs-who-use-substances.pdf 87. Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. The Lancet. 2021;397(10292):2385- 2438. doi:10.1016/S0140-6736(21)00684-X 88. Lachowicz-Scroggins ME, Vuga LJ, Laposky AD, et al. The intersection of women’s health, lung health, and disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2021;321(3):L624-L627. doi:10.1152/ajplung.00333.2021 89. Reusch JEB, Kumar TR, Regensteiner JG, Zeitler PS, Conference Participants. Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span. Endocrinology. 2018;159(1):9-19. doi:10.1210/en.2017-03019 90. Schroeder RA, Brandes J, Buse DC, et al. Sex and Gender Differences in Migraine— Evaluating Knowledge Gaps. Journal of Women’s Health. 2018;27(8):965-973. doi:10.1089/jwh.2018.7274 91. Quinlivan J, Rowe H, Wischmann T, et al. Setting the global research agenda in psychosocial aspects of women’s health – outcomes from ISPOG world conference at The Hague. null. 2020;41(1):1-4. doi:10.1080/0167482X.2020.1695872 92. Manson JE, Bassuk SS, Kaunitz AM, Pinkerton JV. The Women’s Health Initiative trials of menopausal hormone therapy: lessons learned. Menopause. 2020;27(8). https://journals.lww.com/menopausejournal/Fulltext/2020/08000/The_Women_s_Health _Initiative_trials_of_menopausal.14.aspx 93. Graham A, Daly C. (TBC) Coombe Women and Infants University Hospital Physiotherapy Department. Women’s Health Taskforce; 2019. —— 16
Women’s Health Action Plan 2022-2023 – Evidence Summary 94. Wrigley M, O’Riordan F. (TBC) Specialist Perinatal Mental Health Services: Model of Care for Ireland. Women’s Health Taskforce; 2019. 95. Nagle U, Naughton S. Meeting the Needs of Women with Birth Trauma - Rotunda Hospital Specialist Perinatal Mental Health Service. Women’s Health Taskforce; 2021. 96. Kendall-Tacket K. Birth Trauma: The Causes and Consequences of Childbirth-Related Trauma and PTSD. In: Barnes D, ed. Women’s Reproductive Mental Health Across the Lifespan. Springer, Cham; 2014. doi.org/10.1007/978-3-319-05116-1_10 97. Benjamin DR, Frawley HC, Shields N, van de Water ATM, Taylor NF. Relationship between diastasis of the rectus abdominis muscle (DRAM) and musculoskeletal dysfunctions, pain and quality of life: a systematic review. Physiotherapy. 2019;105(1):24-34. doi:10.1016/j.physio.2018.07.002 98. Department of Health. Connecting for Life: Ireland’s Naitonal Strategy to Reduce Suicide 2015-2020.; 2015. Accessed November 12, 2021. https://assets.gov.ie/15758/e6c74742547a48428e4640e3596a3d72.pdf 99. Peeters G, van Schoor NM, Cooper R, Tooth L, Kenny RA. Should prevention of falls start earlier? Co-ordinated analyses of harmonised data on falls in middle-aged adults across four population-based cohort studies. PLOS ONE. 2018;13(8):e0201989. doi:10.1371/journal.pone.0201989 100. Health and Wellbeing: Active Ageing for Older Adults in Ireland. Evidence from The Irish Longitudinal Study on Ageing. The Irish Longitudinal Study on Ageing; 2017. Accessed January 27, 2022. https://tilda.tcd.ie/publications/reports/pdf/w3-key-findings- report/TILDA%20Wave%203%20Key%20Findings%20report.pdf 101. Viner RM, Ozer EM, Denny S, et al. Adolescence and the social determinants of health. The Lancet. 2012;379(9826):1641-1652. doi:10.1016/S0140-6736(12)60149-4 102. Schoep ME, Adang EMM, Maas JWM, De Bie B, Aarts JWM, Nieboer TE. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open. 2019;9(6):e026186. doi:10.1136/bmjopen-2018-026186 103. Coyne I, Comiskey CM, Lalor JG, Higgins A, Elliott N, Begley C. An exploration of clinical practice in sites with and without clinical nurse or midwife specialists or advanced nurse practitioners, in Ireland. BMC Health Serv Res. 2016;16:151. doi:10.1186/s12913-016- 1412-8 104. Comiskey C, Coyne I, Lalor J, Begley C. A national cross-sectional study measuring predictors for improved service user outcomes across clinical nurse or midwife specialist, advanced nurse practitioner and control sites. J Adv Nurs. 2014;70(5):1128-1137. doi:10.1111/jan.12273 105. Davis SF, Enderby P, Harrop D, Hindle L. Mapping the contribution of Allied Health Professions to the wider public health workforce: a rapid review of evidence-based interventions. Journal of Public Health. 2017;39(1):177-183. doi:10.1093/pubmed/fdw023 —— 17
Women’s Health Action Plan 2022-2023 – Evidence Summary 106. Department of Public Expenditure and Reform. Equality Budgeting.; 2019. Accessed November 22, 2021. https://www.gov.ie/en/policy-information/aec432-equality- budgeting/ 107. Department of Public Expenditure and Reform. Code of Practice for the Governance of State Bodies: Annex on Gender Balance, Diversity and Inclusion.; 2020. Accessed November 22, 2021. https://www.gov.ie/en/publication/8e884-code-of-practice-for-the- governance-of-state-bodies-annex-on-gender-balance-diversity-and-inclusion/ 108. European Institute for Gender Equality (EIGE). What Is Gender Mainstreaming. Accessed November 22, 2021. https://eige.europa.eu/gender-mainstreaming/what-is-gender- mainstreaming 109. National Women’s Council Ireland (NWCI). Training Handbook: Gender Mainstreaming in Health.; 2014. Accessed November 22, 2021. https://www.nwci.ie/images/uploads/NWCI_GM_Training_Manual_A4_WEB.pdf —— 18
You can also read